• / Free eNewsletters & Magazine
  • / My Account
Home>Regions>Iceland

Iceland

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. European CHMP Adopts Positive Opinion for Gilead’s Vosevi® (Sofosbuvir/Velpatasvir/Voxilaprevir) for the Treatment of All Chronic Hepatitis C Genotypes

    European CHMP Adopts Positive Opinion for Gilead’s Vosevi® (Sofosbuvir/Velpatasvir/Voxilaprevir) for the Treatment of All Chronic Hepatitis C Genotypes

  2. AerCap and Primera Air Announce Lease Agreement for Two Airbus A321LR Aircraft

    AerCap and Primera Air Announce Lease Agreement for Two Airbus A321LR Aircraft

  3. Iceland's Central Bank Cuts Rates on Strong Króna

    Iceland's Central Bank Cuts Rates on Strong Króna

  4. Ipsen and its partner Exelixis announce independent radiology committee review confirms results from Phase 2 CABOSUN trial of cabozantinib versus sunitinib in previously untreated advanced renal cell ...

    Ipsen and its partner Exelixis announce independent radiology committee review confirms results from Phase 2 CABOSUN trial of cabozantinib versus sunitinib in previously untreated advanced renal cell carcinoma

  5. Verne Global Sets Strategic Roadmap to Manage Advanced Computing Requirements

    Verne Global Sets Strategic Roadmap to Manage Advanced Computing Requirements

  6. News Highlights: Top Global Markets News of the Day

    News Highlights: Top Global Markets News of the Day

  7. Coca-Cola European Partners to Present at Deutsche Bank Global Consumer Conference, Affirms Full-Year 2017 Guidance

    Coca-Cola European Partners to Present at Deutsche Bank Global Consumer Conference, Affirms Full-Year 2017 Guidance

  8. CureDuchenne to Host Webinar with Santhera Pharmaceuticals on SIDEROS Trial

    CureDuchenne to Host Webinar with Santhera Pharmaceuticals on SIDEROS Trial

  9. Exelixis Announces Initiation of Phase 1b Trial of Cabozantinib in Combination with Atezolizumab in Patients with Locally Advanced or Metastatic Solid Tumors

    Exelixis Announces Initiation of Phase 1b Trial of Cabozantinib in Combination with Atezolizumab in Patients with Locally Advanced or Metastatic Solid Tumors

  10. U.K.'s May Faces Pressure to Soften Brexit Approach

    U.K.'s May Faces Pressure to Soften Brexit Approach

12345

©2017 Morningstar Advisor. All right reserved.